Monthly FDA Guidance and Regulatory News Review - June 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Posts about
Regulatory Submissions (6)
FSP/Resourcing: Meeting the Moment with Expert Resources
Clinical trial leaders in small and medium-sized biotech companies regularly find themselves at the...
Monthly FDA Guidance and Regulatory News Review - May 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Monthly FDA Guidance and Regulatory News Review - April 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Monthly FDA Guidance and Regulatory News Review - March 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Regulatory Guidance Monthly Review - February 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Regulatory Guidance Monthly Review - January 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Regulatory Guidance Monthly Review - December 2023
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
FDA CDER’s Accelerating Rare disease Cures (ARC) Program
In 2022, the FDA’s Center for Drug Evaluation and Research (CDER) launched the Accelerating Rare...
Regulatory Guidance Monthly Review - November 2023
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...